CXCL1 and neoplasm: Hao et al. reported that the combination of paclitaxel-PLGA NPs with the pre-implantation of CXCL1-loaded hydrogels at the tumor site resulted in a better tumor suppression than that with paclitaxel-PLGA NPs alone or paclitaxel-liposomes [24].